Published in Surg Endosc on February 08, 2002
Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59
Laparoscopic surgery--15 years after clinical introduction. World J Surg (2006) 1.72
Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc (2007) 1.60
Evidence-based appraisal of antireflux fundoplication. Ann Surg (2004) 1.59
Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc (2011) 1.57
Long-term outcome of laparoscopic Nissen, Toupet, and Thal antireflux procedures for neurologically normal children with gastroesophageal reflux disease. Surg Endosc (2006) 1.56
Influence of spastic motor disorders of the esophageal body on outcomes from laparoscopic antireflux surgery. Surg Endosc (2003) 1.07
Staging laparoscopy for advanced gastric cancer: is it also useful for the group which has an aggressive surgical strategy? World J Surg (2007) 0.94
Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc (2008) 0.90
Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol (2010) 0.90
Laparoscopic Nissen repair: indications, techniques and long-term benefits. Langenbecks Arch Surg (2004) 0.87
Nissen or partial posterior fundoplication: which antireflux procedure has a lower rate of side effects? Langenbecks Arch Surg (2005) 0.86
A prospective nonrandomized comparison of laparoscopic Nissen fundoplication and laparoscopic Toupet fundoplication in Indian population using detailed objective and subjective criteria. J Minim Access Surg (2012) 0.85
Severely disordered esophageal peristalsis is not a contraindication to laparoscopic Nissen fundoplication. Surg Endosc (2006) 0.85
Long-term comparative outcome between laparoscopic total Nissen and Toupet fundoplication: Symptomatic relief, patient satisfaction and quality of life. Surg Endosc (2007) 0.84
EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84
Five-year results of laparoscopic Toupet fundoplication as the primary surgical repair in GERD patients: is it durable? Surg Endosc (2006) 0.83
Laparoscopic partial posterior (Toupet) fundoplication improves esophageal bolus propagation on scintigraphy. Surg Endosc (2007) 0.82
A Meta-Analysis of Randomized Controlled Trials to Compare Long-Term Outcomes of Nissen and Toupet Fundoplication for Gastroesophageal Reflux Disease. PLoS One (2015) 0.82
Gastroesophageal reflux disease: medical or surgical treatment? Gastroenterol Res Pract (2009) 0.81
Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community. World J Surg (2009) 0.81
Reoperative antireflux surgery for dysphagia. Surg Endosc (2010) 0.81
Influence of wrap length on the effectiveness of Nissen and Toupet fundoplications: 5-year results of prospective, randomized study. Surg Endosc (2012) 0.78
Fundoplication for gastroesophageal reflux and factors associated with the outcome 6 to 10 years after the operation: multivariate analysis of prognostic factors using the propensity score. Surg Endosc (2008) 0.78
The Nissen fundoplication: indication, technical aspects and postoperative outcome. Langenbecks Arch Surg (2004) 0.78
Prediction of recurrence after laparoscopic fundoplication for erosive reflux esophagitis based on anatomy-function-pathology (AFP) classification. Surg Endosc (2006) 0.78
Laparoscopic antireflux surgery improves esophageal body motility in patients with severe reflux esophagitis. Surg Today (2013) 0.77
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Anterior partial fundoplication for gastroesophageal reflux disease. Langenbecks Arch Surg (2003) 0.75
Laparoscopic Toupet fundoplication. Langenbecks Arch Surg (2010) 0.75
Laparoscopic Toupet fundoplication for gastroesophageal reflux: a series of 131 neurologically impaired pediatric cases at a single children's hospital. Pediatr Surg Int (2015) 0.75
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology (1986) 3.16
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
[A simple operation for control of reflux esophagitis]. Schweiz Med Wochenschr (1956) 2.78
A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg (1996) 2.49
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux. Br J Surg (1996) 2.11
Laparoscopic Nissen fundoplication. Ann Surg (1994) 1.94
Multicenter prospective evaluation of laparoscopic antireflux surgery. Preliminary report. Surg Endosc (1994) 1.91
Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg (1996) 1.83
Prospective randomized double-blind trial between laparoscopic Nissen fundoplication and anterior partial fundoplication. Br J Surg (1999) 1.75
Oesophageal dysmotility is not associated with poor outcome after laparoscopic Nissen fundoplication. Br J Surg (1998) 1.73
Quality of life and surgical outcome after laparoscopic Nissen and Toupet fundoplication: one-year follow-up. Endoscopy (2000) 1.64
Antireflux surgery in the laparoscopic era. Br J Surg (1998) 1.63
Laparoscopic partial fundoplication vs laparoscopic Nissen-Rosetti fundoplication. Short-term results of 231 cases. Surg Endosc (1997) 1.53
Laparoscopic Nissen fundoplication--200 consecutive cases. Gut (1996) 1.41
A long-term randomized prospective trial of the Nissen procedure versus a modified Toupet technique. Ann Surg (1989) 1.40
Causes of failures of laparoscopic antireflux operations. Surg Endosc (1996) 1.22
Laparoscopic antireflux surgery. What is real progress? Ann Surg (1994) 1.21
Laparoscopic Nissen's fundoplication: preliminary report on ten cases. Surg Endosc (1991) 1.20
Clinical and manometric results of laparoscopic partial (Toupet) and complete (Rosetti-Nissen) fundoplication. Surg Endosc (1996) 1.18
A randomized, prospective comparison of the Nissen fundoplication versus the Toupet fundoplication for gastroesophageal reflux disease. Ann Surg (1997) 1.16
Laparoscopic Nissen fundoplication is a satisfactory alternative to long-term omeprazole therapy. Br J Surg (1995) 1.07
Laparoscopic repair of gastroesophageal reflux disease. Toupet partial fundoplication versus Nissen fundoplication. Surg Endosc (1994) 1.01
Patterns of success and failure with laparoscopic Toupet fundoplication. Surg Endosc (1999) 1.00
The short esophagus: pathophysiology, incidence, presentation, and treatment in the era of laparoscopic antireflux surgery. Ann Surg (2000) 0.99
Laparoscopic reoperations after failed and complicated antireflux operations. Surg Endosc (1995) 0.98
Tailoring antireflux surgery: A randomized clinical trial. World J Surg (1999) 0.98
Complications of laparoscopic fundoplication: the first 100 patients. Surg Laparosc Endosc (1996) 0.90
Laparoscopic 'physiological' antireflux procedure: preliminary results of a prospective symptomatic and objective study. Br J Surg (1995) 0.89
Surgical therapy for GERD: selection of procedures, short- and long-term results. J Clin Gastroenterol (2000) 0.84
Laparoscopic Nissen fundoplication: cost, morbidity, and outcome compared with open surgery. Surg Laparosc Endosc (1996) 0.81
Partial fundoplication for gastroesophageal reflux. Surg Endosc (1997) 0.79
[Errors and dangers of laparoscopic anti-reflux surgery]. Chirurg (1993) 0.77
Gastroesophageal reflux: conventional surgical treatment versus laparoscopy. A prospective study of 61 cases. Surg Laparosc Endosc (1996) 0.76
Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology (2001) 3.38
Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis. Lancet (1996) 2.65
[Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons]. Z Gastroenterol (1996) 2.04
ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr (2002) 1.75
Drug-associated pancreatitis: facts and fiction. Pancreas (1996) 1.75
Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc (2007) 1.60
Scarless cholecystectomy with combined transvaginal and transumbilical approach in a series of 20 patients. Surg Endosc (2008) 1.46
[Staging laparoscopy in Hodgkin's disease. A valid alternative to staging laparotomy]. Dtsch Med Wochenschr (1993) 1.44
[Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (1999) 1.43
The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc (2001) 1.43
[Adult-onset Still's disease]. Med Klin (Munich) (1995) 1.39
Laparoscopic cholecystectomy without visible scar: combined transvaginal and transumbilical approach. Endoscopy (2007) 1.27
Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept (1994) 1.25
Human pancreatic exocrine response to nutrients in health and disease. Gut (2005) 1.16
Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol (1986) 1.14
Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology (1986) 1.14
Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther (2011) 1.14
Nerve growth factor-induced differentiation of PC12 cells: evaluation of changes in RNA and DNA metabolism. J Neurosci (1981) 1.05
[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol (2012) 1.02
Effect of a pneumoperitoneum on the extent and severity of peritonitis induced by gastric ulcer perforation in the rat. Surg Endosc (1995) 1.01
Transvaginal NOTES hybrid cholecystectomy: feasibility results in 68 cases with mid-term follow-up. Endoscopy (2009) 0.98
[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"]. Z Gastroenterol (2009) 0.96
Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology (1985) 0.96
Oroileal transit of slow release 5-aminosalicylic acid. Gut (1993) 0.96
A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides (1989) 0.96
Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc (1986) 0.95
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther (2003) 0.95
Somatostatin 28 and coupling of human interdigestive intestinal motility and pancreatic secretion. Gastroenterology (1992) 0.92
[Leiomyomatosis of the colon: case report and literature review]. Pathologe (2007) 0.90
Photoaffinity labeling and quaternary structure of the acetylcholine receptor from Torpedo californica. Proc Natl Acad Sci U S A (1976) 0.88
Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophys Res Commun (1992) 0.88
[Laparoscopic splenectomy]. Chirurg (1993) 0.87
Diagnostic dilemma in pancreatic lymphoma. Case report and review. Int J Pancreatol (1997) 0.85
Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol (1997) 0.85
Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil (2009) 0.83
[Short practice guideline for the management of gastroesophageal reflux disease]. Dtsch Med Wochenschr (2005) 0.83
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression. Pancreatology (2007) 0.82
Laparoscopic and conventional closure of perforated peptic ulcer. Surg Endosc (1997) 0.82
Laparoscopic vs open repair of gastric perforation and abdominal lavage of associated peritonitis in pigs. Surg Endosc (1998) 0.81
Circadian coupling between pancreatic secretion and intestinal motility in humans. Am J Physiol Gastrointest Liver Physiol (2001) 0.81
[Colpotomy for specimen removal in laparoscopic surgery]. Chirurg (1994) 0.81
Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors. Pancreas (1995) 0.81
A pneumoperitoneum perpetuates severe damage to the ultrastructural integrity of parietal peritoneum in gastric perforation-induced peritonitis in rats. Surg Endosc (1999) 0.81
Exocrine pancreatic function in diabetes mellitus. Eur J Gastroenterol Hepatol (1995) 0.80
[Ondansetron in carcinoid syndrome]. Dtsch Med Wochenschr (1992) 0.80
Workup of a patient with a mass in the head of the pancreas. Pancreas (1998) 0.80
[S3 guideline of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM) to the definition, pathophysiology, diagnosis and treatment of intestinal motility]. Z Gastroenterol (2011) 0.80
[Stenosis of the choledochus by metal clips after laparoscopic cholecystectomy]. Chirurg (1994) 0.79
[Multidisciplinar international classification of the severity of acute pancreatitis: Italian version 2013]. Minerva Med (2013) 0.79
p53 autoantibodies in patients with autoimmune diseases: a quantitative approach. Autoimmunity (1999) 0.79
Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused rat stomach and pancreas preparation. Pancreas (1988) 0.79
Hereditary pancreatitis. Presentation of an additional family. Hepatogastroenterology (1985) 0.78
Repair of infected defects of the chest wall by transposition of greater omentum. Br J Clin Pract (1990) 0.78
Determination of calcium concentration in pancreatic juice with the Corning 940 calcium titrator. Clin Chem (1983) 0.78
Calcium secretion from the feline pancreas. Influence of hormonal and cholinergic secretagogues and of serum calcium. Digestion (1983) 0.78
Stimulatory effect of hypercalcemia on pancreatic secretion is prevented by pretreatment with cholecystokinin and cholinergic agonists. Pancreas (1986) 0.78
Pancreatic and gastric responses to gastric versus jejunal beer in humans. Pancreas (1988) 0.78
[IBD ahead 2010--Answering important questions in Crohn's disease treatment]. Z Gastroenterol (2011) 0.78
Effects of experimental chronic hypercalcemia on feline exocrine pancreatic secretion. Gastroenterology (1982) 0.78
[S2k guideline for chronic constipation: definition, pathophysiology, diagnosis and therapy]. Z Gastroenterol (2013) 0.77
Effects of acute hypercalcemia on exocrine pancreatic secretion in the cat. Gastroenterology (1985) 0.77
Short-bowel syndrome: an update on the therapeutic approach. Scand J Gastroenterol (1997) 0.77
Gastroparesis after radiation. Successful treatment with carbachol. Dig Dis Sci (1986) 0.77
[Pain therapy in irritable bowel syndrome]. Schmerz (2014) 0.76
[Acute hepatorenal failure in hereditary fructose intolerance]. Med Klin (Munich) (1993) 0.76
Randomized, controlled trial of 2 L polyethylene glycol plus ascorbate components versus sodium phosphate for bowel cleansing prior to colonoscopy for cancer screening. Curr Med Res Opin (2014) 0.76
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors. Eur J Pharmacol (1994) 0.76
Workup of a patient with familial pancreatic cancer. Pancreas (1999) 0.76
[Efficacy of freeze-dried Lactobacilli in functional diarrhoe: a pilot study]. Dtsch Med Wochenschr (2012) 0.76
[Combined transvaginal and transumbilical approach for cholecystectomy with no visible scarring]. Chirurg (2009) 0.75
[Pathogenesis and pathophysiology of sigmoid diverticulitis]. Chirurg (1995) 0.75
Effect of carbon dioxide pneumoperitoneum on bacteraemia and endotoxaemia in an animal model of peritonitis. Br J Surg (1995) 0.75
Paralytic ileus responding to somatostatin therapy: first manifestation of a VIPoma. Dig Dis Sci (1989) 0.75
[Gastroesophageal reflux disease: tailoring laparoscopic fundoplication to preoperative esophageal motility still mandatory?]. Z Gastroenterol (2012) 0.75
[Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea]. Med Klin (Munich) (1986) 0.75
[Azathioprine: live long without probation?]. Z Gastroenterol (2010) 0.75
[Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic]. Z Gastroenterol (2011) 0.75
[From rural practice to the Mecca of medicine: the Mayo Clinic]. Med Klin (Munich) (1986) 0.75
[PPI-sensitive diarrhea - unusual case of an adolescent with sporadic gastrinoma]. Dtsch Med Wochenschr (2012) 0.75
[Topic Complex IV: Erosive reflux disease (ERD)]. Z Gastroenterol (2005) 0.75
[Visceral medicine: a successful collaboration]. Dtsch Med Wochenschr (2012) 0.75
[Intestinal function tests]. Praxis (Bern 1994) (2005) 0.75
[Muscle weakness, skin manifestations and para-hilar space-occupying lesions in a 59-year-old patient. Cushing disease and pulmonary lymph node tuberculosis]. Internist (Berl) (2003) 0.75
[How extensively should irritable bowel syndrome be investigated? Expensive bowel sounds in the abdomen]. MMW Fortschr Med (2002) 0.75
[Chronic intestinal pseudo-obstruction: pathogenesis, diagnosis and therapy]. Z Gastroenterol (2002) 0.75
[Rational and efficient diagnosis in different stages of Crohn's disease]. Z Gastroenterol (2012) 0.75
[Proper patient counseling, recommended nutrition, specific medication. The basics of irritable bowel syndrome therapy]. MMW Fortschr Med (2002) 0.75
[Neural control of pancreatic secretion]. Z Gastroenterol (1987) 0.75
[Clinicopathologic conference. Motor unsteadiness, vertigo, weight loss and micturition disorders in a 46-year-old female (Shy-Drager syndrome or pernicious anemia?)]. Med Klin (Munich) (1986) 0.75
[Autoimmune pancreatitis]. Z Gastroenterol (2002) 0.75
[Causes and diagnostic assessment of upper abdominal pain]. MMW Fortschr Med (2009) 0.75
[Effect of chronic inflammatory bowel diseases on fertility and pregnancy]. Internist (Berl) (2002) 0.75
[Foetor ex ore and halitosis. Differential diagnosis and therapy]. Med Klin (Munich) (1986) 0.75
Best practice & research in clinical gastroenterology. Preface. Best Pract Res Clin Gastroenterol (2009) 0.75